Norway· NO-ID_85B52239-19E5-4EDD-B4F0-C587C54E5224
Procysbi
A mercaptamine product containing mercaptamine, registered in Norway by Chiesi Farmaceutici S.p.a.. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Mercaptamine is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AA04 (mercaptamine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Mercaptamine · ATC A16AA04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of mercaptamine costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mercaptamine · price per daily dose (2 g)
USD · FX 28 Sept 2026
- CH Switzerland$589.95
The record
At a glance
FEST (Norway)- Active substance
- Mercaptamine
- Manufacturer
- Chiesi Farmaceutici S.p.a.
- Country
- Norway (NO)
- ATC code
- A16AA04
- ATC class
- Mercaptamine
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_85B52239-19E5-4EDD-B4F0-C587C54E5224
- no_varenummer43664760NOK 5925
- gtin5028613003077
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mercaptamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumProcysbi 25 mgChiesi Farmaceutici
- CanadaPROCYSBIAMGEN CANADA INC
- SpainPROCYSBI 25 MG CAPSULAS DURAS GASTRORRESISTENTESChiesi Farmaceutici S.P.A.
- FinlandPROCYSBIChiesi Farmaceutici S.p.A.
- FrancePROCYSBI 25 mg, gélule gastro-résistanteCHIESI FARMACEUTICI
- United KingdomProcysbi 25mg gastro-resistant capsulesChiesi Ltd
- IrelandPROCYSBI 25 mg gastro-resistant hard capsulesChiesi Farmaceutici S.p.A.
- IcelandProcysbiChiesi Farmaceutici S.p.A.*
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Cystadrops, Cystagon
- Liechtenstein · Cystadrops, Cystagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a3d21dd5-8c06-4659-b10b-60358d3f7f9e GET /v1/drugs/a3d21dd5-8c06-4659-b10b-60358d3f7f9e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Enterokapsel, hard",
"source": "fest",
"status": "A",
"atc_name": "Merkaptamin",
"merkevare_id": "ID_85B52239-19E5-4EDD-B4F0-C587C54E5224",
"name_form_strength": "Procysbi enterokaps 25 mg",
"prescription_group": "C"
}See everything about mercaptamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.